Karen Smith
2015
In 2015, Karen Smith earned a total compensation of $3.1M as Executive Vice President, Research & Development and CMO at Jazz Pharmaceuticals.
Compensation breakdown
| Bonus | $290,000 |
|---|---|
| Non-Equity Incentive Plan | $130,000 |
| Option Awards | $1,034,350 |
| Salary | $337,981 |
| Stock Awards | $1,254,103 |
| Other | $67,492 |
| Total | $3,113,926 |
Smith received $1.3M in stock awards, accounting for 40% of the total pay in 2015.
Smith also received $290K in bonus, $130K in non-equity incentive plan, $1M in option awards, $338K in salary and $67.5K in other compensation.
Rankings
In 2015, Karen Smith's compensation ranked 3,038th out of 13,638 executives tracked by ExecPay. In other words, Smith earned more than 77.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,038 out of 13,638 | 78th |
Division Manufacturing | 1,076 out of 5,187 | 79th |
Major group Chemicals And Allied Products | 398 out of 1,857 | 79th |
Industry group Drugs | 312 out of 1,531 | 80th |
Industry Pharmaceutical Preparations | 248 out of 1,179 | 79th |
Source: SEC filing on June 20, 2017.
Smith's colleagues
We found four more compensation records of executives who worked with Karen Smith at Jazz Pharmaceuticals in 2015.